The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: Cell-specific alteration of the cell cycle

Biochemical Pharmacology

Volumn 64, Issue 9, 2002, Pages 1375-1386

  Pozo Guisado, Eulalia ^a   Alvarez Barrientos, Alberto ^b   Mulero Navarro, Sonia ^a   Santiago Josefat, Belen ^a   Fernandez Salguero, Pedro M ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Apoptosis; Breast cancer cells; Cell cycle blockade; Chemoprevention; Resveratrol; Ribonucleotide reductase

Indexed keywords

APOPTOSIS INDUCING FACTOR; PROTEIN P21; PROTEIN P27; PROTEIN P53; RESVERATROL; RIBONUCLEOTIDE REDUCTASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SPECIFICITY; CELL STRAIN MCF 7; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CELL SURVIVAL; ENZYME INHIBITORS; HUMANS; RIBONUCLEOTIDE REDUCTASES; STILBENES; TUMOR CELLS, CULTURED;

EID: 0036829930     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01296-0     Document Type: Article

References (38)

1. Celotti E., Ferrarini R., Zironi R., Conte L.S. Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J. Chromatogr. A. 730:1996;47-52.
2. Lamikanra O., Grimm C.C., Rodin J.B., Inyang Y.D. Hydroxylated stilbenes in selected American wines. J. Agric. Food Chem. 44:1996;1111-1115.
3. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30:1997;91-113.
4. Romero-Perez A.I., Ibern-Gomez M., Lamuela-Raventos R.M., Torre-Boronat M.C. Piceid, the major resveratrol derivative in grape juices. J. Agric. Food Chem. 47:1999;1533-1536.
5. Maxwell S., Cruickshank A., Thorpe G. Red wine and antioxidant activity in serum. Lancet. 344:1994;193-194.
6. Goldberg D.M., Hahn S.E., Parkes J.G. Beyond alcohol: beverage consumption and cardiovascular mortality. Clin. Chim. Acta. 237:1995;155-187.
7. Rotondo S., Rajtar G., Manarini S., Celardo A., Rotilio D., deGaetano G., Evangelista V., Cerletti C. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br. J. Pharmacol. 123:1998;1691-1699.
8. Pace-Asciak C.R., Rounova O., Hahn S.E., Diamandis E.P., Goldberg D.M. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta. 246:1996;163-182.
9. Orsini F., Pelizzoni F., Verotta L., Aburjai T. Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-β-D-glucopyranoside and related compounds. J. Nat. Prod. 60:1997;1082-1087.
10. Wang M., Jin Y., Ho C.-T. Evaluation of resveratrol derivatives as potential antioxidants and identification of a reaction product of resveratrol and 2,2-diphenyl-1-picryhydrazyl radical. J. Agric. Food Chem. 47:1999;3974-3977.
11. Karlsson J., Emgard M., Brundin P., Burkitt M.J. trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide. J. Neurochem. 75:2000;141-150.
12. Werz O., Szellas D., Henseler M., Steinhilber D. Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity. Mol. Pharmacol. 54:1998;445-451.
13. Martinez J., Moreno J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 59:2000;865-870.
14. Gehm B.D., McAndrews J.M., Chien P., Jameson J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14138-14143.
15. Lu R., Serrero G. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J. Cell Physiol. 179:1999;297-304.
16. Hall M., Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68:1996;67-108.
17. Hajduch M., Havlieek L., Vesely J., Notovny R., Mihal V., Strnad M. Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs. Adv. Exp. Med. Biol. 457:1999;341-353.
18. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1999;1501-1512.
19. Boulamwini J.K. Cell cycle molecular targets in novel anticancer drug discovery. Curr. Pharm. Des. 6:2000;379-392.
20. Naik P.N., Karrim J., Hanahan D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev. 10:1996;2105-2116.
21. Deigner H.P., Kinscherf R. Modulating apoptosis: current applications and prospects for future drug development. Curr. Med. Chem. 6:1999;399-414.
22. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
23. Mgbonyebi O.P., Russo J., Russo I.H. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol. 12:1998;865-869.
24. Dörrie J., Gerauer H., Wachter Y., Zunino S.J. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 61:2001;4731-4739.
25. Tinhofer I., Bernhard D., Senfter M., Anether G., Loeffler M., Kroemer G., Kofler R., Csordas A., Greil R. Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J. 15:2001;1613-1615.
26. Ahmad N., Adhami V.M., Afaq F., Feyes D.K., Mukhtar H. Resveratrol causes WAF-1/p21-mediated G1-arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin. Cancer Res. 7:2001;1466-1473.
27. Mossmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;63-66.
28. Shewach D.S. Quantitation of deoxyribonucleoside 5′-triphosphates by a sequential boronate and anion-exchange high-pressure liquid chromatographic procedure. Anal. Biochem. 206:1992;178-182.
29. Fontecave M., Lepoivre M., Elleingand E., Gerez C., Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421:1998;277-279.
30. Sugarbaker E.V. The complex clinical model of metastasis. Adv. Exp. Med. Biol. 2:1981;235-278.
31. Tsujino T., Yoshida K., Nakayama H., Ito H., Shimosato T., Tahara E. Alterations of oncogenes in metastatic tumours of human gastric carcinomas. Br. J. Cancer. 62:1990;226-230.
32. Hsieh T.-Z., Burfeind P., Laud K., Backer J.M., Traganos F., Darzynkiewicz Z., Wu J.M. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int. J. Oncol. 15:1999;245-252.
33. Ragione F.D., Cucciolla V., Borriello A., Pietra V.D., Racioppi L., Soldati G., Manna C., Galletti P., Zappia V. Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem. Biophys. Res. Commun. 250:1998;53-58.
34. Joe A.K., Liu H., Suzui M., Vural M.E., Xiao D., Weinstein I.B. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8:2002;893-903.
35. Padmanabhan J., Park D.S., Greene L.A., Shelanski M.L. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis. J. Neurosci. 19:1999;8747-8756.
36. Martin-Romero F.J., Santiago-Josefat B., Correa-Bordes J., Gutierrez-Merino C., Fernandez-Salguero P.M. Potassium-induced apoptosis in rat cerebellar granule cells involves cell-cycle blockade at the G1/S transition. J. Mol. Neurosci. 15:2000;155-165.
37. Wolter F., Akoglu B., Clausnitzer A., Stein J. Downregulation of the cyclin D1/CDK4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J. Nutr. 131:2001;2197-2203.
38. Moreno J.J. Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblasts growth. J. Pharmacol. Exp. Ther. 294:2000;333-338.